Revenue
Margin
Demand
Guidance
Tone
Event Participants
Executives
2
Abhiraj Choksey (Vice Chairman & Managing Director), Vivek Thakur (Chief Financial Officer)
Analysts
12
Abhishek (Anand Rathi Investor), Aditya Khetan (SMIFS Institutional Equities), Chandpal Vilk (Individual Investor), Deepak Poddar (Sapphire Capital), Farokh Pandole (Avestha Fund Management), Harsha (Merisis Advisors), Jasdeep Walia (Clockvine), Mehul Panjwani (40 Cents), Om Dutt (Individual Investor), Raman Kerti (Sequent Investments), Sajal Kapoor (Antifragile Thinking), Sujit Marar (Individual Investor)
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Revenue | ₹526 crores | Highest-ever quarterly revenue, +40% YoY, driven by improved price realizations despite lower sales volumes |
| Sales Volume | Down 10–12% YoY | Export-led decline from West Asia geopolitical disruptions and Strait of Hormuz closure; domestic volumes up ~10% |
| Operating EBITDA | ₹117 crores | +203% YoY; includes ~2% EBITDA margin benefit from inventory gains |
| EBITDA Margin | 22.3% | Up from 10.3% YoY (+1,200 bps); management does not annualize this level, cites 15–16% average as sustainable |
| Profit After Tax | ₹79 crores | +311% YoY (vs ₹19 crores); PAT margin 15.01% vs 5.11% (+990 bps) |
| Net Cash Position | ~₹30–40 crores | Down from ~₹70 crores at March-end due to higher working capital from elevated raw material prices |
| Capital Expenditure (Committed) | ₹220 crores | NBR de-bottlenecking (~₹130–140 crores) + SB latex/other synthetic latex expansions; ~15–20% spent, self-funded so far |
Geographic & Segment Commentary
- Domestic Market: Domestic volumes grew ~10% YoY despite industry-wide disruptions; demand is strong across paper, construction, rubber goods, and other end-industries with no meaningful demand issues reported.
- Exports / MENA Region: Export volumes declined 10–12% due to West Asia geopolitical developments, Strait of Hormuz closure, and higher ocean freight costs; MENA remains a strategic region, orders returned during the temporary lull in the war, and management expects a quick reversal once the war ends.
- Nitrile Latex (Glove Segment): Margins improved versus FY25/FY26 lows but have not yet fully recovered to pre-COVID 15–16% EBITDA levels; Q1 margins exceeded 15% across the board; COVID-era global overcapacity is normalizing, supported by US duties on Chinese gloves (now 100%).
- NBR (Nitrile Butadiene Rubber): Company holds ~30% Indian market share with the rest served by imports; expansion via innovative de-bottlenecking will add ~100% capacity at ₹130–140 crores, on stream Q1 FY28.
- Synthetic Latex (SB Latex & Others): Capacity expansion planned on stream by end of Q1 FY28 (June 2027); combined with NBR project, adds
₹600 crores to top line (40% increase). - ApcoBuild: Continues to perform reasonably well; remains a small, growing part of the overall business with no major updates.
Company-Specific & Strategic Commentary
- Operational Resilience & Risk Management: Intentional multi-year investments including dual fuel sources (gas/coal), multiple raw material sources per input across geographies, and rapid procurement decisions enabled uninterrupted customer supply and above-market margins during Q1 supply disruptions; positioned as a core, sustainable competitive capability rather than a one-off.
- Capacity Expansion Program (₹220 crores): NBR de-bottlenecking adds
100% capacity for ₹130–140 crores (vs ₹200–250 crores originally estimated), on stream April 2027; SB latex/other synthetic latex by June 2027; combined additions expected to generate ~₹600 crores incremental revenue (40% growth). - Nitrile Latex Stage 2: Project plan ready with minimal civil construction required, enabling faster execution; decision expected within 3–4 months pending assessment of the China factor and new Malaysian capacity additions.
- Product Portfolio Diversification: Added ~25 new products post-COVID across eight industries (construction, paper, textiles, oil field applications, etc.); nitrile latex range spans 6–7 grades for medical, industrial, and household gloves.
- Capital Allocation: Return on capital remains the primary driver; balance sheet is net cash (~₹30–40 crores) with near-zero debt; CapEx self-funded to date; dividend payout expected to rise with sustained profitability.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| EBITDA Margin | 15–16% average, long-term | Management confident of 15–16% average margins as the company scales; quarterly margins will vary (Q1 22.3% includes ~2% inventory gain, not annualized) |
| NBR Capacity Expansion | On stream Q1 FY28 (April 2027) | Adds ~100% capacity via de-bottlenecking; final date to be confirmed in Q3 FY27 earnings call |
| SB Latex / Synthetic Latex Expansion | On stream by June 2027 | Couple of months after NBR; combined ₹220 crores capex adds |
| Nitrile Latex Stage 2 | Decision within 3–4 months | Project plan ready and executable quickly; awaiting longer-term margin visibility given China supply and Malaysia capacity additions |
| Export Volume Recovery | Quick reversal once war ends | Orders returned during the temporary lull; MENA disruption viewed as a short-term blip rather than structural |
Risks & Constraints
| Risk | Context |
|---|---|
| West Asia geopolitical disruption | Strait of Hormuz closure and ocean freight spikes reduced export volumes 10–12% in Q1; recovery depends on war ending, though orders returned during the brief lull, suggesting demand remains intact |
| Crude oil price volatility | Realizations and input costs swing with oil prices; high crude currently supports margins but may cap volume growth; August–September realizations likely to rise again if crude continues upward |
| Nitrile latex competitive capacity | China supply factor and new Malaysian capacity (coming on stream June–August) could pressure spreads; management deferred the Stage 2 decision 3–4 months to assess these dynamics |
| Margin normalization | Q1's 22.3% EBITDA margin includes ~2% inventory gains and supply-constrained pricing; management does not annualize this and guides to 15–16% average, implying quarters below that are possible |
| Working capital and liquidity | Higher raw material prices lifted inventory values and receivables, reducing net cash from ~₹70 crores to ~₹30–40 crores; CapEx outflow accelerates in Q3–Q4 with equipment deliveries, requiring debt in coming quarters |
Q&A Highlights
EBITDA Quality and Sustainable Margins
- Question: Can you quantify inventory gains as a percentage of EBITDA, and what is a sustainable margin level? (Aditya Khetan, SMIFS)
- Answer: ~2% of EBITDA came from inventory gains; management is confident of 15–16% average EBITDA margins over time, with quarterly variation around that — Q1's 22.3% should not be annualized. (Abhiraj Choksey)
- Follow-up: Is 15–16% the right sustainable level for this year? (Deepak Poddar, Sapphire Capital)
- Answer: With oil prices this high, margins could sustain but volumes may not grow; difficult to call normalized levels this year. (Abhiraj Choksey)
Export Volume Decline and MENA Disruption
- Question: How much did volumes drop, and why? (Aditya Khetan)
- Answer: Overall volumes down 10–12%, entirely export-led; MENA is a strategic region and Strait of Hormuz closure halted customer production and logistics. Domestic volumes grew 10%; orders returned during the lull and should reverse quickly when the war ends. (Abhiraj Choksey)
Nitrile Latex Cycle and Stage 2 Decision
- Question: Where are we in the nitrile latex cycle, and what is the update on Stage 2 of the Valia plant? (Aditya Khetan; Farokh Pandole, Avestha)
- Answer: Margins improved versus the prior two years but nitrile latex has not yet fully recovered to pre-COVID 15–16% EBITDA; Q1 was above 15% across the board. Stage 2 project plan is ready with minimal civil work; decision in 3–4 months after assessing the China factor and Malaysian capacity additions. (Abhiraj Choksey)
NBR Expansion Economics
- Question: Earlier you said NBR expansion made no sense without anti-dumping duty support — what changed? (Aditya Khetan)
- Answer: The team found an innovative de-bottlenecking route to add ~100% capacity for ₹130–140 crores versus ₹200–250 crores earlier; margins are improving, no major global NBR expansions are coming on stream, and India's cost competitiveness is strengthening. (Abhiraj Choksey)
Operational Resilience — Built or Incidental?
- Question: What changed in the design of the business that allowed record profitability despite export disruption? (Sajal Kapoor, Antifragile Thinking)
- Answer: Intentional, multi-year capability building: dual fuel sources (gas/coal), multiple raw material sources per input across geographies, and rapid procurement decisions that MNC competitors could not replicate; these are sustainable competitive strengths, though such opportunity windows won't repeat every quarter. (Abhiraj Choksey)
Growth Ambition and Doubling Throughput
- Question: Can throughput double in five years in a normal environment, and what prevents it? (Sajal Kapoor)
- Answer: Announced capex adds
₹600 crores (40%); there is no structural constraint — the balance sheet is strong, nearly debt-free and net cash, and adjacency opportunities are being evaluated. Management is targeting ambitious growth and will announce specific plans when ready. (Abhiraj Choksey)
Working Capital, Net Cash and CapEx Funding
- Question: How do working capital days and inventory holding compare, and what is the net cash position? (Abhishek, Anand Rathi; Farokh Pandole)
- Answer: Inventory days are unchanged — the rise is purely in value due to higher raw material prices. Net cash is ~₹30–40 crores (down from ~₹70 crores in March); ~15–20% of the ₹220 crores capex has been spent (advances and civil works), with equipment outflows concentrated in Q3–Q4; capex has been self-funded so far, with debt expected in the next couple of quarters. (Vivek Thakur; Abhiraj Choksey)
Q2 Demand and Realization Outlook
- Question: How is demand one month into Q2, and have realizations increased further given crude volatility? (Raman Kerti, Sequent Investments)
- Answer: Realizations corrected early in Q2 as oil fell, but are likely to rise again in August–September with crude; domestic demand is strong across paper, construction, and rubber goods — no demand issues outside MENA. (Abhiraj Choksey)
Rupee Depreciation and Export Opportunity
- Question: Has rupee depreciation expanded the export opportunity pool? (Jasdeep Walia, Clockvine)
- Answer: The effect is largely neutral — raw materials are dollar-denominated, so depreciation raises input costs alongside export realizations; no significant net benefit. (Abhiraj Choksey)
Competitive Landscape — Imports and Global Capacity
- Question: How did NBR imports trend, and are global competitors adding capacity? (Aditya Khetan)
- Answer: NBR imports continued as the company holds only ~30% Indian market share; there are minimal latex imports into India. Some Asian competitors announced synthetic latex expansions, but they are staggered and prudent; no Europe/US expansions are planned, and India/SE Asia demand growth should absorb capacity over 3–5 years. (Abhiraj Choksey)
Key Takeaway
Apcotex Industries delivered its best-ever quarter in Q1 FY27, with revenue of ₹526 crores (+40% YoY), operating EBITDA of ₹117 crores (+203% YoY, 22.3% margin), and PAT of ₹79 crores (+311% YoY), driven by improved realizations, ~2% inventory gains, and intentional operational resilience — dual fuel sources, multi-geography raw material sourcing, and rapid procurement — that allowed the company to capitalize on global supply constraints. Domestic volumes rose 10% while exports fell 10–12% on West Asia disruptions, which management views as a short-term blip. Management guides toward 15–16% average EBITDA margins and expects the ₹220 crores NBR/SB latex expansion (adding ~₹600 crores revenue) on stream by Q1 FY28, with a nitrile latex Stage 2 decision within 3–4 months. Key watch points include crude price volatility, export normalization post-conflict, and competitive capacity additions in Asia.